3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
2
Other hematologic neoplasm
2
Myeloid
2
Lymphoid
2
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
NET
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Tobacco Use Disorder
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pheochromocytoma
1
Pharyngeal Neoplasms
1
Penile Neoplasms
1
Parotid Neoplasms
1
Parathyroid Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Interventions
Peripheral Blood Stem Cell Transplantation
41
fludarabine phosphate
36
Cyclophosphamide
35
Mycophenolic Acid
28
Whole-Body Irradiation
26
Cyclosporine
25
Busulfan
24
Tacrolimus
21
Antilymphocyte Serum
20
Filgrastim
17
Methotrexate
16
Etoposide
15
Melphalan
13
Methylprednisolone
12
Radiotherapy
11
Psychiatric Rehabilitation
11
Flow Cytometry
11
Therapeutics
10
Polymerase Chain Reaction
8
Rituximab
7
Bortezomib
7
tanespimycin
6
sargramostim
6
Vorinostat
6
Sirolimus
6
Gemcitabine
6
Cord Blood Stem Cell Transplantation
6
Transplantation
5
Thiotepa
5
Carboplatin
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Molecular Diagnostic Techniques
×
Dermatologic
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled